The inhibition of invasion by statins in the aggressive MDA-MB-231 triple-negative breast cancer cells has been attributed to the suppression of the RhoA/ROCK/NF-kB signaling pathway [65]. The gene discussed is RHOA; the disease is triple-negative breast carcinoma.